Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to -$425000.0.

  • Bioharvest Sciences' Cash from Investing Activities rose 995.76% to -$425000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year increase of 2813.57%. This contributed to the annual value of -$3.0 million for FY2024, which is 10535.96% down from last year.
  • Per Bioharvest Sciences' latest filing, its Cash from Investing Activities stood at -$425000.0 for Q3 2025, which was up 995.76% from -$592000.0 recorded in Q2 2025.
  • Over the past 5 years, Bioharvest Sciences' Cash from Investing Activities peaked at -$222000.0 during Q1 2024, and registered a low of -$1.9 million during Q2 2024.
  • Its 3-year average for Cash from Investing Activities is -$606111.1, with a median of -$440000.0 in 2023.
  • The largest annual percentage gain for Bioharvest Sciences' Cash from Investing Activities in the last 5 years was 6937.4% (2025), contrasted with its biggest fall of 20630.63% (2025).
  • Quarter analysis of 3 years shows Bioharvest Sciences' Cash from Investing Activities stood at -$291000.0 in 2023, then crashed by 37.46% to -$400000.0 in 2024, then dropped by 6.25% to -$425000.0 in 2025.
  • Its Cash from Investing Activities stands at -$425000.0 for Q3 2025, versus -$592000.0 for Q2 2025 and -$680000.0 for Q1 2025.